Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning - Certain Pacific Oysters may be unsafe due to a marine biotoxin which causes Paralytic Shellfish Poisoning


Product photos are available at: https://bit.ly/2GfXXnx

OTTAWA, July 19, 2019 /CNW/ - Industry is recalling certain Pacific oysters from the marketplace due to a marine biotoxin which causes Paralytic Shellfish Poisoning. Consumers should not consume the recalled products described below.

The following products have been sold in British Columbia, Alberta and Ontario. 

Recalled products

 

Processor

Product

Size

Code

Harvest Date

Union Bay Seafood Ltd.

Pacific oysters, Mica's Petite

Effingham Inlet

5 dozen

Location: BC 23-6

Landfile: 1403799

Lot: 20190715NW

14 July 2019

Union Bay Seafood Ltd.

Pacific oysters

Effingham Inlet Xs

5 dozen

Location: BC 23-6

Landfile: 1403799

Lot: 20190715NW

14 July 2019

 

Intercity Packers Ltd.

Oyster N/Shell

Effingham XSM

5 dozen

Harvest Location: BC 23-6

LF#: 1403799

P.O. No.: 114994

7/14/2019

 

What you should do

Check to see if you have recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Paralytic shellfish toxins are a group of natural toxins that sometimes accumulate in bivalve shellfish that include oysters, clams, scallops, mussels and cockles. Non-bivalve shellfish, such as whelks, can also accumulate Paralytic Shellfish Poisoning (PSP) toxins. These toxins can cause Paralytic Shellfish Poisoning (PSP) if consumed. Symptoms of Paralytic Shellfish Poisoning (PSP) include tingling and numbness of the lips, tongue, hands and feet, and difficulty swallowing with an onset of a few minutes and up to 10 hours after consumption. In severe situations, this can proceed to difficulty walking, muscle paralysis, respiratory paralysis and death.

Background

This recall was triggered by Canadian Food Inspection Agency (CFIA) test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Illnesses

There have been no reported illnesses associated with the consumption of these products.

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: